Message to Shareholders and Investors


First of all, we wholeheartedly apologize to our shareholders and all other stakeholders for the trouble caused by a violation of the Antimonopoly Act in a joint bid by our subsidiary which operates an ethical pharmaceuticals wholesaling business.

For the Alfresa Group strengthening governance is our top priority. All of our officers and employees are working hard to reform the company by reviewing our business practices and our corporate culture so that we might once again earn your trust.

With the Alfresa Group’s philosophy “We create and deliver a fresh life for all”, we will approach each act of business in good faith, and offer steadfast support to communities through the stable supply of products and services to meet the needs of medical institutions, our valued clients.

These days, we see structural changes afoot in the healthcare industry, as birthrates decline and the population ages, as advanced treatments and pharmaceuticals like regenerative medicine are developed, and as governments and the medical and nursing care team up in the Community-based Integrated Care System. Under the 2019-21 Mid-term Management Plan The Challenge of Further Growth “Together with Health, Together with Communities,” we are seeking to spark growth in the broader healthcare field, including all aspects from prevention to treatment and nursing care, through capital alliances and other collaboration with a variety of partners in different industries that offer a wealth of pioneering technologies, products, services, and expertise.

We hope you’ll join us on our journey of discovery and progress.